arrow
T

Takashi Taguchi

primary medical science department
H指数:49
被引数:9,608

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of esaxerenone vs trichlormethiazide for the treatment of uncontrolled essential hypertension in Japanese patients with type 2 diabetes mellitus: a subanalysis of the EXCITE-HT study

E saxerenone与trichlormethiazide治疗日本2型糖尿病合并未控制原发性高血压患者的疗效与安全性:EXCITE-HT研究的亚组分析

2025-12-230
OAAI
Effect of N-terminal pro B-type natriuretic peptide levels on the efficacy and safety of esaxerenone vs trichlormethiazide for the treatment of Japanese patients with uncontrolled essential hypertension: a subanalysis of the EXCITE-HT study

N末端B型利钠肽原水平对依 saxerenone 与三氯噻嗪治疗日本未控制原发性高血压患者疗效和安全性的影响:EXCITE-HT 研究的亚组分析

2025-11-070
OAAI
Efficacy and safety of esaxerenone with and without sodium–glucose cotransporter-2 inhibitor use in hypertensive patients with type 2 diabetes mellitus: a pooled analysis of five clinical studies

恩杂鲁胺在有和无钠-葡萄糖协同转运蛋白-2抑制剂使用情况下对伴有2型糖尿病的高血压患者的有效性和安全性:一项五项临床研究的合并分析

2025-09-010
OAAI
Efficacy and safety of esaxerenone in hypertensive patients with chronic kidney disease, with or without type 2 diabetes mellitus: a pooled analysis of five clinical studies

依 saxerenone 在慢性肾脏病合并或不合并2型糖尿病的高血压患者中的有效性与安全性:一项五项临床研究的合并分析

2025-06-300
OAAI
Efficacy and Safety of Esaxerenone in Hypertensive Patients with Left Ventricular Hypertrophy (ESES-LVH) Study: A Multicenter, Open-Label, Prospective, Interventional Study
2024-02-049
OAAI
Efficacy and safety of the G protein-coupled receptor 119 agonist DS-8500a in Japanese type 2 diabetes mellitus patients with inadequate glycemic control on sitagliptin: A phase 2 randomized placebo-controlled study

G蛋白偶联受体119激动剂DS-8500a西格列汀血糖控制不佳的日本2型糖尿病患者的疗效和安全性: 一项2期随机安慰剂对照研究

2018-05-2411
OAAI
Renal thrombotic microangiopathies/thrombotic thrombocytopenic purpura in a patient with primary Sjogren's syndrome complicated with IgM monoclonal gammopathy of undetermined significance

原发性干燥综合征合并未明确意义的IgM单克隆丙种病患者的肾脏血栓性微血管病/血栓性血小板减少性紫癜

2010-07-2213
PREAI